Cargando…

Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets

The viral envelope glycoproteins are essential for entry into their host cells and studied extensively for designing vaccines. We hypothesize that the glycosylation on the HIV-1 viral envelope glycoprotein 41(gp41) at critical residues offers viral escape from the specific immune surveillant neutral...

Descripción completa

Detalles Bibliográficos
Autores principales: Christdas, Johnson, Manoharan, Prabu, Harshavardhan, Shakila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369679/
https://www.ncbi.nlm.nih.gov/pubmed/25848164
http://dx.doi.org/10.6026/97320630011057
_version_ 1782362778114195456
author Christdas, Johnson
Manoharan, Prabu
Harshavardhan, Shakila
author_facet Christdas, Johnson
Manoharan, Prabu
Harshavardhan, Shakila
author_sort Christdas, Johnson
collection PubMed
description The viral envelope glycoproteins are essential for entry into their host cells and studied extensively for designing vaccines. We hypothesize that the glycosylation on the HIV-1 viral envelope glycoprotein 41(gp41) at critical residues offers viral escape from the specific immune surveillant neutralizing antibodies Z13, 4E10 and 10E8 targeted to their linear epitopes in the Membrane Proximal External Region (MPER). The glycosylation occurring on the 50th residue (Asparagine) contained in the target (NWFNIT) can mask itself to be inaccessible for these neutralizing antibodies. The glycosylation rate of the epitopes which are shared by the Z13, 4E10 and 10E8 neutralizing antibodies of HIV-1 were predicited in silico. We analyzed the reliable frequency of glycosylation on the HIV-1 envelope gp41 using prediction tools to unravel the plausibility of the glycosylation by a mannose at 50th residue in the 59 amino acid long HIV-gp41 trimer (PDBID: 2M7W and 2LP7). It is evident that the glycosylation by a mannose that masks these targets is possible only when the 50th amino-acid is N (Asparagine, Asn) which is not possible when N is mutated to D (Aspartatic acid, Asp). The additive advantage for the retrovirus is its error-prone reverse transcriptase which can choose to copy these survivable mutants with Asn N-50 that can be glycosylated as explained by the Copy-choice model. So the glycan shields varying in their intensity and patterns have to be essentially studied to understand the viral escape strategies that will give a way forward towards a successful vaccine that can elicit a neutralizing antibody response to confer protection.
format Online
Article
Text
id pubmed-4369679
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-43696792015-04-06 Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets Christdas, Johnson Manoharan, Prabu Harshavardhan, Shakila Bioinformation Hypothesis The viral envelope glycoproteins are essential for entry into their host cells and studied extensively for designing vaccines. We hypothesize that the glycosylation on the HIV-1 viral envelope glycoprotein 41(gp41) at critical residues offers viral escape from the specific immune surveillant neutralizing antibodies Z13, 4E10 and 10E8 targeted to their linear epitopes in the Membrane Proximal External Region (MPER). The glycosylation occurring on the 50th residue (Asparagine) contained in the target (NWFNIT) can mask itself to be inaccessible for these neutralizing antibodies. The glycosylation rate of the epitopes which are shared by the Z13, 4E10 and 10E8 neutralizing antibodies of HIV-1 were predicited in silico. We analyzed the reliable frequency of glycosylation on the HIV-1 envelope gp41 using prediction tools to unravel the plausibility of the glycosylation by a mannose at 50th residue in the 59 amino acid long HIV-gp41 trimer (PDBID: 2M7W and 2LP7). It is evident that the glycosylation by a mannose that masks these targets is possible only when the 50th amino-acid is N (Asparagine, Asn) which is not possible when N is mutated to D (Aspartatic acid, Asp). The additive advantage for the retrovirus is its error-prone reverse transcriptase which can choose to copy these survivable mutants with Asn N-50 that can be glycosylated as explained by the Copy-choice model. So the glycan shields varying in their intensity and patterns have to be essentially studied to understand the viral escape strategies that will give a way forward towards a successful vaccine that can elicit a neutralizing antibody response to confer protection. Biomedical Informatics 2015-02-28 /pmc/articles/PMC4369679/ /pubmed/25848164 http://dx.doi.org/10.6026/97320630011057 Text en © 2015 Biomedical Informatics This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original author and source are credited.
spellingShingle Hypothesis
Christdas, Johnson
Manoharan, Prabu
Harshavardhan, Shakila
Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets
title Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets
title_full Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets
title_fullStr Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets
title_full_unstemmed Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets
title_short Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets
title_sort neutralization function affected by single amino acid replacement in the hiv-1 antibody targets
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369679/
https://www.ncbi.nlm.nih.gov/pubmed/25848164
http://dx.doi.org/10.6026/97320630011057
work_keys_str_mv AT christdasjohnson neutralizationfunctionaffectedbysingleaminoacidreplacementinthehiv1antibodytargets
AT manoharanprabu neutralizationfunctionaffectedbysingleaminoacidreplacementinthehiv1antibodytargets
AT harshavardhanshakila neutralizationfunctionaffectedbysingleaminoacidreplacementinthehiv1antibodytargets